Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Serratia rubidaea as an invasive pathogen

P R Ursua1, M J Unzaga, P Melero

  • 1Department of Microbiology, Hospital de Basurto, Bilbao, Bizkaia, Spain.

Journal of Clinical Microbiology
|January 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[First wave of the COVID-19 pandemic in Navarre, Spain, February-June 2020].

Anales del sistema sanitario de Navarra·2021
Same author

Antimicrobial activity of ceftolozane-tazobactam against Enterobacterales and Pseudomonas aeruginosa recovered during the Study for Monitoring Antimicrobial Resistance Trends (SMART) program in Spain (2016-2018).

Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia·2021
Same author

Antimicrobial susceptibility trends and evolution of isolates with extended spectrum β-lactamases among Gram-negative organisms recovered during the SMART study in Spain (2011-2015).

Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia·2018
Same author

[Comparative study of HIV-1/2 antibody confirmatory assay: Geenius™ versus INNO-LIA™].

Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia·2016
Same author

Cost-Effectiveness Analysis of a Shingles Vaccination Program to Prevent Herpes Zoster And Post- Herpetic Neuralgia in the Spanish Setting.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2016
Same author

Moderate influenza vaccine effectiveness against hospitalisation with A(H3N2) and A(H1N1) influenza in 2013-14: Results from the InNHOVE network.

Human vaccines & immunotherapeutics·2016

Serratia rubidaea biotype 1 caused a bile duct infection in a patient with bile tract carcinoma. Antibiotic treatment successfully cleared the infection.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Oncology

Background:

  • Bile tract carcinoma can lead to biliary obstruction and increase the risk of infection.
  • Invasive procedures in patients with biliary obstruction may introduce opportunistic pathogens.

Observation:

  • Serratia rubidaea biotype 1 was identified in the bile and blood cultures of a patient with common bile duct obstruction due to bile tract carcinoma.
  • The patient had undergone invasive procedures prior to the isolation of the bacteria.

Findings:

  • Serratia rubidaea biotype 1 is an opportunistic pathogen that can cause serious infections in immunocompromised or debilitated patients.
  • The isolated strain demonstrated susceptibility to antibiotic treatment, leading to infection clearance.

Related Experiment Videos

Implications:

  • This case highlights the potential for Serratia rubidaea biotype 1 to cause healthcare-associated infections in patients with biliary tract malignancies.
  • Prompt diagnosis and appropriate antibiotic therapy are crucial for managing such infections and improving patient outcomes.
  • Further research may be warranted to understand the specific risk factors and optimal management strategies for Serratia rubidaea biotype 1 infections in oncology patients.